543520 — Global Longlife Hospital and Research Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹330.75m
- IN₹454.26m
- IN₹135.15m
Annual cashflow statement for Global Longlife Hospital and Research, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.6 | 18.2 | 57.1 | 27.1 | -22.7 |
| Depreciation | |||||
| Non-Cash Items | -1.16 | -0.828 | 27 | 7.04 | -348 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 29.5 | 59.2 | -1.25 | -450 | 308 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 39 | 95.3 | 94.2 | -404 | -50.7 |
| Capital Expenditures | -1.06 | -0.423 | -4.75 | -20.2 | -10.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.682 | 0.598 | 4.89 | 1.22 | 2.31 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.38 | 0.175 | 0.132 | -19 | -8.18 |
| Financing Cash Flow Items | -24.1 | -24.3 | -13.1 | -4 | -7.68 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -30.5 | -100 | -96.6 | 457 | 26.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.08 | -4.77 | -2.22 | 33.8 | -32.2 |